Redcliffe Labs

Redcliffe Labs, a unit of US-based Redcliffe Lifetech Inc., was founded in 2018 and operates as a diagnostics service provider. The company offers a comprehensive range of pathology and radiology tests, aiming to deliver high-quality healthcare solutions. Its services encompass diagnostic testing, omnichannel capabilities, and laboratory services, enhancing patient care and accessibility. Redcliffe Labs is committed to innovation and service excellence within the healthcare sector, focusing on accuracy and efficiency.

With a workforce ranging from 1,000 to 5,000 employees, Redcliffe Labs operates across 4 locations, demonstrating a growing operational footprint. The company's dedication to building a strong team is evident, and details about its personnel can be explored through Meet Redcliffe Labs' team. This focus on human capital supports its mission to provide reliable and advanced diagnostic services. The company's strategic growth is further underscored by its recent funding rounds, including a Series C round of $42 million in September 2024, supported by investors like LeapFrog Investments, Spark Growth Ventures, and Ifu.

Redcliffe Labs has achieved substantial financial milestones, reporting a revenue of $752.1M. This financial strength enables continued investment in research, development, and expansion of its service offerings. The company's robust financial performance is a testament to its effective business model and market penetration within the diagnostics industry. Further insights into its financial standing and performance metrics are available via Explore financial highlights. Redcliffe Labs continues to drive advancements in diagnostic healthcare, focusing on accuracy, efficiency, and patient-centric services.